Impact of Personalized Counseling on IVF Patient Experience
Evaluation of in Vitro Fertilisation Patients' Experience With a Personalized Prognostic Counseling Strategy and Its Impact on Treatment Utilization and Discontinuation
This study is testing if personalized counseling can improve the experiences and outcomes for women undergoing IVF compared to standard counseling.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 366 (estimated) |
| Ages | 18 Years to 43 Years |
| Sex | Female |
| Sponsor | Ginefiv Academic / other |
| Locations | 2 sites (Barcelona and 1 other locations) |
| Trial ID | NCT06319573 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effects of personalized prognostic counseling on the experiences and treatment utilization of women undergoing IVF. It consists of two phases: the first phase involves standard counseling, while the second phase utilizes the Univfy PreIVF report for counseling. Participants will complete anonymous questionnaires to assess their experiences, and various metrics such as treatment utilization rates and live birth rates will be measured over a 12-month follow-up period. The goal is to compare the outcomes between the two counseling approaches.
Who should consider this trial
Good fit: Ideal candidates are women aged 18-43 who are undergoing IVF treatment using their own eggs.
Not a fit: Patients who are perimenopausal, menopausal, or have a history of very poor IVF results may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the IVF experience and improve treatment outcomes for patients.
How similar studies have performed: Other studies have shown promising results with personalized counseling approaches in fertility treatments, suggesting potential for success in this study.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients between 18-43 in age and their healthcare providers have determined that IVF treatment using the patients' own eggs is indicated. Exclusion Criteria:specific to this study only (these are not contraindications to using the Univfy® PreIVF Report): * Same sex couples * Patients undergoing DuoStim and/or PGT-M/-SR * Patients considering egg freezing rather than IVF * Patients considering the use of donor eggs or gestational carrier Patients with contraindications to receiving the Univfy® PreIVF Report For Patients Under 40 Using Their Own Eggs. Those contraindications are: * Patients who are perimenopausal or menopausal * Patients who have very poor IVF results in the past, including: * extremely poor oocyte/embryo quality, no embryos to transfer, * no euploid embryos on PGT-A, no blastocysts in extended culture
Where this trial is running
Barcelona and 1 other locations
- Ginefiv S.L — Barcelona, Spain (Recruiting)
- Ginefiv S.L — Madrid, Spain (Recruiting)
Study contacts
- Study coordinator: Xinxin L Miao
- Email: x.lin@ginefiv.com
- Phone: +34930400200
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.